Precision medicine: Clarity for the complexity of dementia

Brenna Cholerton; Eric B. Larson; Joseph F. Quinn; Cyrus P. Zabetian; Ignacio F. Mata; C. Dirk Keene; Margaret Flanagan; Paul K. Crane; Thomas J. Grabowski; Kathleen S. Montine; Thomas J. Montine

doi:10.1016/j.ajpath.2015.12.001

Precision medicine: Clarity for the complexity of dementia

Brenna Cholerton, Eric B. Larson, Joseph F. Quinn, Cyrus P. Zabetian, Ignacio F. Mata, C. Dirk Keene, Margaret Flanagan, Paul K. Crane, Thomas J. Grabowski, Kathleen S. Montine, Thomas J. Montine

Neurology

Research output: Contribution to journal › Review article › peer-review

45 Scopus citations

Abstract

Three key elements to precision medicine are stratification by risk, detection of pathophysiological processes as early as possible (even before clinical presentation), and alignment of mechanism of action of intervention(s) with an individual's molecular driver(s) of disease. Used for decades in the management of some rare diseases and now gaining broad currency in cancer care, a precision medicine approach is beginning to be adapted to cognitive impairment and dementia. This review focuses on the application of precision medicine to address the clinical and biological complexity of two common neurodegenerative causes of dementia: Alzheimer disease and Parkinson disease.

Original language	English (US)
Pages (from-to)	500-506
Number of pages	7
Journal	American Journal of Pathology
Volume	186
Issue number	3
DOIs	https://doi.org/10.1016/j.ajpath.2015.12.001
State	Published - Mar 1 2016

ASJC Scopus subject areas

Pathology and Forensic Medicine

Access to Document

10.1016/j.ajpath.2015.12.001

Cite this

@article{3d69302b332c44eb8f902b06619f83da,

title = "Precision medicine: Clarity for the complexity of dementia",

abstract = "Three key elements to precision medicine are stratification by risk, detection of pathophysiological processes as early as possible (even before clinical presentation), and alignment of mechanism of action of intervention(s) with an individual's molecular driver(s) of disease. Used for decades in the management of some rare diseases and now gaining broad currency in cancer care, a precision medicine approach is beginning to be adapted to cognitive impairment and dementia. This review focuses on the application of precision medicine to address the clinical and biological complexity of two common neurodegenerative causes of dementia: Alzheimer disease and Parkinson disease.",

author = "Brenna Cholerton and Larson, {Eric B.} and Quinn, {Joseph F.} and Zabetian, {Cyrus P.} and Mata, {Ignacio F.} and Keene, {C. Dirk} and Margaret Flanagan and Crane, {Paul K.} and Grabowski, {Thomas J.} and Montine, {Kathleen S.} and Montine, {Thomas J.}",

year = "2016",

month = mar,

day = "1",

doi = "10.1016/j.ajpath.2015.12.001",

language = "English (US)",

volume = "186",

pages = "500--506",

journal = "American Journal of Pathology",

issn = "0002-9440",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Precision medicine

T2 - Clarity for the complexity of dementia

AU - Cholerton, Brenna

AU - Larson, Eric B.

AU - Quinn, Joseph F.

AU - Zabetian, Cyrus P.

AU - Mata, Ignacio F.

AU - Keene, C. Dirk

AU - Flanagan, Margaret

AU - Crane, Paul K.

AU - Grabowski, Thomas J.

AU - Montine, Kathleen S.

AU - Montine, Thomas J.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Three key elements to precision medicine are stratification by risk, detection of pathophysiological processes as early as possible (even before clinical presentation), and alignment of mechanism of action of intervention(s) with an individual's molecular driver(s) of disease. Used for decades in the management of some rare diseases and now gaining broad currency in cancer care, a precision medicine approach is beginning to be adapted to cognitive impairment and dementia. This review focuses on the application of precision medicine to address the clinical and biological complexity of two common neurodegenerative causes of dementia: Alzheimer disease and Parkinson disease.

AB - Three key elements to precision medicine are stratification by risk, detection of pathophysiological processes as early as possible (even before clinical presentation), and alignment of mechanism of action of intervention(s) with an individual's molecular driver(s) of disease. Used for decades in the management of some rare diseases and now gaining broad currency in cancer care, a precision medicine approach is beginning to be adapted to cognitive impairment and dementia. This review focuses on the application of precision medicine to address the clinical and biological complexity of two common neurodegenerative causes of dementia: Alzheimer disease and Parkinson disease.

UR - http://www.scopus.com/inward/record.url?scp=84959019693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959019693&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2015.12.001

DO - 10.1016/j.ajpath.2015.12.001

M3 - Review article

C2 - 26724389

AN - SCOPUS:84959019693

SN - 0002-9440

VL - 186

SP - 500

EP - 506

JO - American Journal of Pathology

JF - American Journal of Pathology

IS - 3

ER -

Precision medicine: Clarity for the complexity of dementia

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this